Hypothyroidism and cardiovascular disease: Factors, mechanism and future perspectives

Current Medicinal Chemistry

Volumn 20, Issue 35, 2013, Pages 4411-4418

  Sharma, Anil K ^a   Arya, R ^a   Mehta, R ^a   Sharma, R ^a   Sharma, A K ^b  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b MAYO CLINIC   (United States)

Author keywords

Cardiovascular disease; Drugs; Hypothyroidism; Lipids; Metals; Thyroid hormones

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CIPROFLOXACIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; IODINE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIOTRIX; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MYOSIN HEAVY CHAIN; PHOSPHOLAMBAN; POTASSIUM; RIFAMPICIN; SELENIUM; SODIUM; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACTION POTENTIAL; ACTIVE TRANSPORT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; AUTOIMMUNE THYROIDITIS; BLOOD FLOW; BODY MASS; BODY TEMPERATURE; BODY WEIGHT; BORDERLINE HYPERTENSION; BRADYCARDIA; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CIRCULATION; COMA; CONFUSION; CONSTIPATION; DEATH; DEPRESSION; DIABETES MELLITUS; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; DYSPNEA; ENDOTHELIAL DYSFUNCTION; FATIGUE; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEMODYNAMICS; HORMONE DEFICIENCY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHERMIA; HYPOTHYROIDISM; INSULIN RESISTANCE; IODINE DEFICIENCY; ISCHEMIC HEART DISEASE; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; LUNG FUNCTION; MEMBRANE FLUIDITY; MENTAL DISEASE; METABOLIC SYNDROME X; MORBIDITY; MUSCLE CRAMP; MYXEDEMA; PREVALENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RISK FACTOR; SARCOPLASMIC RETICULUM; SELENIUM DEFICIENCY; SINUS NODE; SLEEP; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE SYNTHESIS; THYROTROPIN BLOOD LEVEL; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR RESISTANCE;

CARDIOVASCULAR DISEASES; HUMANS; HYPOTHYROIDISM; RISK FACTORS;

EID: 84887873434     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113206660255     Document Type: Article

References (71)

1. Demers, L.M.; Spencer, C.A. Laboratory medicine practise guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin. Endocrinol. (Oxf)., 2003, 58(2), 138-140.
2. Dillmann, W.H. Biochemical basis of thyroid hormone action in the heart. Am. J. Med., 1990, 88(6), 626-630.
3. Chapidze, G.; Dolidze, N.; Williams, M.; Sharadze, E.; Latsabidze, N. Peculiarities of lipid profile parameters in cardiac patients with hypo-and hyperthyroidism. Georgian Med. News, 2006, 133, 44-46.
4. Dillmann, W.H. Diabetes and thyroid-hormone-induced changes in cardiac function and their molecular basis. Annu. Rev. Med., 1989, 40, 373-394.
5. Klein, I.; Danzi, S. Thyroid disease and the heart. Circulation, 2007, 116(15), 1725-1735.
6. Duntas, L.H. Thyroid disease and lipids. Thyroid, 2002, 12(4), 287-293.
7. Klein, I.; Ojamaa, K. The cardiovascular system in hypothyroidism. In: Braverman, L.E.; Utiger, R.D.; Eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8 th edn. Philadelphia: Lippincott Williams & Wilkins, 2000; pp. 777-782.
8. Fredlund, B.O.; Olsson, S.B. Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. Acta. Med. Scand., 1983, 213(3), 231-235.
9. Endo, T.; Komiya, I.; Tsukui, T. Re-evaluation of a possible high incidence of hypertension in hypothyroid patients. Am. Heart J., 1979, 98(6), 684-688.
10. Saito, I.; Ito, K.; Saruta, T. Hypothyroidism as a cause of hypertension. Hypertension, 1983, 5(1), 112-115.
11. Streeten, D.H.; Anderson, G.H.; Howland, T. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension, 1988, 11(1), 78-83.
12. Fletcher, A.K.; Weetman, A.P. Hypertension and hypothyroidism. J. Hum. Hypertens., 1998, 12(2), 79-82.
13. Fommei, E.; Iervasi, G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J. Clin. Endocrinol. Metab., 2002, 87(5), 1996-2000.
14. Crowley, W.F.; Ridgway, E.C.; Bough, E.W. Non-invasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N. Engl. J. Med., 1977, 296(1), 1-6.
15. Wieshammer, S.; Keck, F.S.; Waitzinger, J. Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can. J. Physiol. Pharmacol., 1989, 67(9), 1007-1010.
16. Canaris, G.J.; Manowitz, N.R.; Mayor, G.; Ridgway, C. The Colorado Thyroid Disease Prevalence Study. Arch. Intern. Med., 2000, 160(4), 526-534.
17. Tunbridge, W.M.G.; Evered, D.C.; Hall, R. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol (Oxf)., 1977, 7(6), 481-493.
18. Biondi, B.; Fazio, S.; Palmieri, E.A. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab., 1999, 84(6), 2064-2067.
19. Di Bello, V.; Monzani, F.; Giorgi, D. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J. Am. Soc. Echocardiogr., 2000, 13(9), 832-840.
20. Monzani, F.; Di Bello, V.; Caraccio, N. Effects of levo-thyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J. Clin. Endocrinol. Metab., 2001, 86(3), 1110-1115.
21. Vitale, G.; Galderisi, M.; Lupoli, G.A. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J. Clin. Endocrinol. Metab., 2002, 87(9), 4350-4355.
22. Brenta, G.; Mutti, L.A.; Schnitman, M. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am. J. Cardiol., 2003, 91(11), 1327-1330.
23. Jukie, T.; Labar, E.; Kusie, Z. Subclinical Hypothyroidism. Acta. Clin. Croat., 2006, 40, 313-317.
24. Surks, M.I.; Ortiz, E.; Daniels, G.H.; Sawin, C.T.; Col, N.F.; Cobin, R.H. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 2004, 291(2), 228-238.
25. Owen, P.J.; Sabit, R.; Lazarus, J.H. Thyroid disease and vascular function. Thyroid, 2007, 17(6), 519-524.
26. Biondi, B. Cardiovascular effects of mild hypothyroidism. Thyroid, 2007, 17(7), 625-630.
27. Vinzio, S.; Brafin-Busch, M.S.; Schlienger, J.L.; Goichot, B. Cardiac consequences of clinical dysthyroidism, pathophysiological, clinical and epidemiologic data. Presse Med., 2005, 34(16 Pt 1), 1153-1160.
28. Everts, M.E.; Verhoeven, F.A.; Bezstarosti, K.; Moerings, E.P.; Hennemann, G et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology, 1996, 137, 4235-4242.
29. Osman, F.; Gammage, M.D.; Franklyn, J.A. Thyroid disease and its treatment: short term and long term cardiovascular consequences. Curr. Opin. Pharmacol., 2001, 1(6), 626-631.
30. Danzi, S.; Klein, I. Thyroid hormones and the cardiovascular system. Minerava Endocrinol., 2004, 29(3), 139-150.
31. Orzechowska-Pawitoic, A.; Lewczuk, A.; Sworczak, K. The influence of thyroid hormones on homocysteine and atherosclerotic vascular disease. Endokrynol. Pol., 2005, 56(2), 194-202.
32. Dillmann, W.H.; Rohrer, D.; Popovich, B.; Barrieux, A. Thyroid hormone induced changes in cardiac proteins and mRNAs. Horm. Metab. Res. Suppl., 1987, 17, 26-29.
33. Bindels, A.J.; Westendorp, R.G.; Frolich, M. et al. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin. Endocrinol (Ofx)., 1999, 50(2), 217-220.
34. Pirich, C.; Mullner, M.; Sinzinger, H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J. Clin. Epidemiol., 2000, 53(6), 623-629.
35. Moolman, J.A. Thyroid hormone and the heart. Cardiovasc. J. S. Afr., 2009, 13(4), 159-163.
36. Brent, G.A. The molecular basis of thyroid hormone action. N. Engl. J. Med., 1994, 331(13), 847-853.
37. Morkin, E. Regulation of myosin heavy chain genes in the heart. Circulation, 1993, 87(5), 1451-1460.
38. Ojamaa, K.; Klemperer, J.D.; MacGilvray, S.S. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology, 1996, 137(3), 802-808.
39. Kiss, E.; Jakab, G.; Kranias, E.G. Thyroid hormone induced alteration in phospholamban protein expression: regulatory effects on sarcoplasmic reticulum Ca2+transport and myocardial relaxation. Circ. Res., 1994, 75(2), 245-251.
40. Rush, J.; Danzi, S.; Klein, I. Role of thyroid disease in the development of statin-induced myopathy. The Endocrinologist, 2006, 16, 279-285.
41. Biondi, B.; Palmieri, E.A.; Lombardi, G.; Fazio, S. Effects of thyroid hormones on cardiac function: the relative importance of heart rate, loading conditions and the myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J. Clin. Endocrinol. Metab., 2002, 87, 968-974.
42. Althaus, B.U.; Staub, J.J.; Leche, A.R.; Oberhansli, A.; Stahelin, H.B. LDL/HDL-Changes in Subclinical Hypothyroidism: Possible risk factors for Coronary Heart Disease. Clin. Endocrinol., 1988, 28(2), 157-163.
43. Sasaki, S.; Kawai, K.; Honjo, Y.; Nakamura, H. Thyroid hormones and lipid metabolism. Nihon Rinsho, 2006, 64(12), 2323-2329.
44. Akinci, B.; Comlekci, A.; Yener, S.; Demir, T.; Bayraktar, F. et al. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism. Hormones (Athens), 2007, 6(4), 327-333.
45. Hashemipour, M.; Hoysepian, S.; Kelishadi, R.; Iranpou, R.; Hadian, R. Permanent and transient congenital hypothyroidism in Isfahan-Iran. J. Med. Screen., 2009, 16(1), 11-16.
46. Staub, J.J.; Althaus, B.U.; Engler, H.; Ryff, A.S.; Trabucco, P. et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic effect on peripheral target tissues. Am. J. Med., 1992, 92(6), 631-642.
47. Frankyln, J.A.; Daykin, J.; Betteridge, J.; Hughes, E.A.; Holder, R.; Jones, S.R.; Sheppard, M.C. Thyroxine replacement therapy and circulating lipid concentrations. Clin. Endocrinol. (Oxf)., 1993, 38(5), 453-459.
48. Tan, K.C.B.; Shiu, S.W.M.; Kung, A.W.C. Effect of thyroid dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein. J. Clin. Endocrinol. Metab., 1998, 83(8), 2921-2924.
49. Pearce, E.N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr. Cardiol. Rep., 2004, 6(6), 451-456.
50. Lee, W.Y.; Suh, J.Y.; Rhee, E.J.; Park, J.S.; Sung, K.C.; Kim, S.W. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch. Med. Res., 2007, 35(6), 540-545.
51. Abbas, J.M.; Chakraborty, J.; Akanji, A.O.; Doi, S.A. Hypothyroidism results in small dense LDL independent of IRS traits and hypertriglyceridemia. Endocr. J., 2008, 55(2), 381-389.
52. Pearce, E.N.; Wilson, P.W.F.; Yang, Q.; Vasan, R.S.; Braverman, L.E. Thyroid function and Lipid Subparticle sizes in Patients with short term Hypothyroidism and a population based cohort. J. Clin. Endocrinol. Metab., 2008, 93(3), 888-894.
53. Shantha, G.P.S.; Kumar, A.A.; Jeyachandran, V.; Rajamanickam, D.; Rajkumar, Salim, S.; Subramanian, K.K.; Natesan, S. Association between Primary hypothyroidism and metabolic syndrome and role of C reactive protein: a cross-sectional study from South India. Thyroid Res., 2009, 2(1), 2.
54. Cappola, A.R.; Ladenson, P.W. Hypothyroidism and Atherosclerosis. J. Clin. Endocrinol. Metab., 2003, 88(6), 2438-2444.
55. Prakash, A.; Lal, A.K. Serum Lipids in Hypothyroidism: Our Experience. Indian J. Clin. Biochem., 2006, 21(2), 153-155.
56. Alkazaz, F.F.; Alemami, S.A.; Taai, M.H. Influence of Sodium and Potassium Levels by Thyroid Hormones Disorder in Sera of Female Patients with Cardiovascular Diseases. Journal of Al-Nahrain University, 2012, 15(2), 29-34.
57. Lei, J.; Bhargava, M.; Ingbar, D.H. Cell-specific signal transduction pathways regulating Na+-K+-ATPase. Focus on "Short-term effects of thyroid hormones on the Na+-K+-ATPase activity of chick embryo hepatocytes during development: focus on signal transduction". Am. J. Physiol. Cell. Physiol., 2009, Doi:10.1152/ajpcell.00 553.2008.
58. Arya, R.; Singh, A.; Sharma, A.K. Increase in Serum Lipid Levels of Hypothyroid Patients may Pose a Cardiovascular Risk but Unchanged HDL Levels Could be a Saviour. Int. J. Biotech. Bioengg., 2012, 3(3), 109-116.
59. Roberts, C.G.; Ladenson, P.W. Hypothyroidism. Lancet., 2004, 363(9411), 793-803.
60. Roos, A.; Linn-Rasker, S.P.; van Domburg, R.T.; Tijssen, J.P.; Berghout, A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch. Intern. Med., 2005, 165(15), 1714-1720.
61. Bolk, N.; Visser, T.J.; Kalsbeek, A.; van Domburg, R.T.; Berghout, A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin. Endocrinol., 2007, 66(1), 43-48.
62. Goldberg, A.S.; Tirona, R.G.; Asher, L.J.; Kim, R.B.; Van Uum, S.H. Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption. Thyroid, 2013. [Epub ahead of print]
63. Grozinsky-Glasberg, S.; Fraser, A.; Nahshoni, E.; Weizman, A.; Leibovici, L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: metaanalysis of randomized controlled trials. J. Clin. Endocrinol. Metab., 2006, 91(7), 2592-2599.
64. Appelhof, B.C.; Peeters, R.P.; Wiersinga, W.M. et al. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/ 3,5,3-triiodothyronine therapy. J. Clin. Endocrinol. Metab., 2005, 90(11), 6296-6299.
65. Chakera, A.J.; Pearce, S.H.S.; and Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug. Des. Devel. Ther., 2012, 6, 1-11.
66. Sanmartin, C.; Plano, D.; Font, M.; Palop, J.A. Selenium and clinical trials: new therapeutic evidence for multiple diseases. Curr. Med. Chem., 2011, 18(30), 4635-4650.
67. Triggiani, V.; Tafaro, E.; Giagulli, V.A.; Sabbà, C.; Resta, F.; Licchelli, B.; Guastamacchia, E. Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocr. Metab. Immune Disord. Drug Targets, 2009, 9(3), 277-294.
68. Al-Juboori , I.A.; Al-Rawi, R.; A-Hakeim, H.K. Estimation of Serum Copper, Manganese, Selenium, and Zinc in Hypothyroidism Patients. IUFS. J. Biol., 2009, 68(2), 121-126.
69. Watts, D.L. The Nutritional Relationships of the Thyroid. J. Orthomol. Med., 1989, 4(3), 165-169.
70. Ertek, S.; Cicero, A.F.; Caglar, O.; and Erdogan, G. Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation. Hormones (Athens), 2010, 9(3), 263-8.
71. Lee, R.; Margaritis, M.; Channon, K.M.; Antoniades, C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr. Med. Chem., 2012,19(16), 2504-2520.